ASHOK THERUVATH to Radiopharmaceuticals
This is a "connection" page, showing publications ASHOK THERUVATH has written about Radiopharmaceuticals.
Connection Strength
0.715
-
Mechanoporation enables rapid and efficient radiolabeling of stem cells for PET imaging. Sci Rep. 2022 02 22; 12(1):2955.
Score: 0.182
-
Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans. Mol Imaging Biol. 2020 06; 22(3):722-729.
Score: 0.162
-
Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRI. Radiology. 2020 07; 296(1):143-151.
Score: 0.161
-
Comparison of whole-body DW-MRI with 2-[18F]FDG PET for staging and treatment monitoring of children with Langerhans cell histiocytosis. Eur J Nucl Med Mol Imaging. 2023 05; 50(6):1689-1698.
Score: 0.049
-
Diagnostic Accuracy of 2-[18F]FDG-PET and whole-body DW-MRI for the detection of bone marrow metastases in children and young adults. Eur Radiol. 2022 Jul; 32(7):4967-4979.
Score: 0.045
-
One-stop local and whole-body staging of children with cancer. Pediatr Radiol. 2022 Feb; 52(2):391-400.
Score: 0.043
-
Differentiation of benign and malignant lymph nodes in pediatric patients on ferumoxytol-enhanced PET/MRI. Theranostics. 2020; 10(8):3612-3621.
Score: 0.040
-
Whole-body PET/MRI of Pediatric Patients: The Details That Matter. J Vis Exp. 2017 12 19; (130).
Score: 0.034